Should I buy or sell Avantor stock right now?

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AVTR shares. View AVTR analyst ratings or view top-rated stocks .

What is Avantor's stock price target for 2024?

11 analysts have issued 12 month target prices for Avantor's shares. Their AVTR share price targets range from $21.00 to $30.00. On average, they predict the company's stock price to reach $24.05 in the next year. This suggests a possible upside of 12.5% from the stock's current price. View analysts price targets for AVTR or view top-rated stocks among Wall Street analysts .

How have AVTR shares performed in 2023?

Avantor's stock was trading at $21.09 at the start of the year. Since then, AVTR shares have increased by 1.4% and is now trading at $21.38. View the best growth stocks for 2023 here .

Are investors shorting Avantor?

Avantor saw a increase in short interest in November. As of November 15th, there was short interest totaling 31,680,000 shares, an increase of 9.1% from the October 31st total of 29,040,000 shares. Based on an average daily volume of 7,580,000 shares, the short-interest ratio is presently 4.2 days. View Avantor's Short Interest .

When is Avantor's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 2nd 2024. View our AVTR earnings forecast .

How were Avantor's earnings last quarter?

Avantor, Inc. (NYSE:AVTR) released its earnings results on Friday, October, 27th. The company reported $0.25 EPS for the quarter, hitting the consensus estimate of $0.25. The business had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a trailing twelve-month return on equity of 15.34% and a net margin of 5.18%. The company's revenue for the quarter was down 7.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.34 EPS.

What ETFs hold Avantor's stock?

ETFs with the largest weight of Avantor (NYSE:AVTR) stock in their portfolio include Harbor Health Care ETF (MEDI) , Putnam BioRevolution ETF (SYNB) , Nuveen ESG Mid-Cap Value ETF (NUMV) , First Trust Health Care AlphaDEX Fund (FXH) , Invesco Zacks Mid-Cap ETF (CZA) , First Trust Innovation Leaders ETF (ILDR) and Natixis Vaughan Nelson Mid Cap ETF (VNMC) . Vanguard Extended Market ETF (VXF) .

What guidance has Avantor issued on next quarter's earnings?

Avantor issued an update on its FY 2023 earnings guidance on Friday, October, 27th. The company provided EPS guidance of $1.02-$1.06 for the period, compared to the consensus EPS estimate of $1.07. The company issued revenue guidance of -.

What other stocks do shareholders of Avantor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Johnson & Johnson (JNJ) , NVIDIA (NVDA) , Procter & Gamble (PG) , RTX (RTX) , Alibaba Group (BABA) , CVS Health (CVS) , Home Depot (HD) , Pfizer (PFE) and QUALCOMM (QCOM) .

When did Avantor IPO?

(AVTR) raised $3 billion in an initial public offering (IPO) on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Who are Avantor's major shareholders?

Avantor's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Boston Partners (4.15%), Canada Pension Plan Investment Board (3.30%), Wellington Management Group LLP (1.34%), Meritage Group LP (1.32%), Robeco Schweiz AG (1.21%) and American Century Companies Inc. (1.13%). Insiders that own company stock include Christi Shaw , Christophe Couturier , David D Petratis, Devashish Ohri , Frederic Vanderhaegen , Gerard Brophy , James Bramwell , Jo Natauri , Justin Miller , Michael Stubblefield , Michael Wondrasch , Rajiv Gupta , Steven W Eck and Thomas A Szlosek . View institutional ownership trends .

How do I buy shares of Avantor?

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Avantor Stock Price, News & Analysis (NYSE:AVTR)

$21.38

+0.20 (+0.94%)

(As of 12/1/2023 ET)

Compare

Today's Range: $20.84
▼
$21.44
50-Day Range: $17.15
▼
$21.57
52-Week Range: $16.63
▼
$25.25

Volume: 7.23 million shs
Average Volume: 6.11 million shs
Market Capitalization: $14.46 billion

P/E Ratio: 39.59
Dividend Yield: N/A
Price Target: $24.05

Avantor MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.73 Rating Score
Upside/Downside: 12.5% Upside
$24.05 Price Target
Short Interest: Bearish
4.68% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -2.12
Upright™ Environmental Score
News Sentiment: 0.39
Based on 15 Articles This Week
Insider Trading: Selling Shares
$156,389 Sold Last Quarter
Proj. Earnings Growth: 6.73%
From $1.04 to $1.11 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars

Medical Sector

560th out of 957 stocks

Analytical Instruments Industry

15th out of 27 stocks

2.4

Analyst's Opinion

Consensus Rating
Avantor has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $24.05, Avantor has a forecasted upside of 12.5% from its current price of $21.38.
Amount of Analyst Coverage
Avantor has only been the subject of 4 research reports in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
4.68% of the outstanding shares of Avantor have been sold short.
Short Interest Ratio / Days to Cover
Avantor has a short interest ratio ("days to cover") of 4.2.
Change versus previous month
Short interest in Avantor has recently increased by 9.09%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Avantor does not currently pay a dividend.
Dividend Growth
Avantor does not have a long track record of dividend growth.

3.4

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Avantor has received a 38.55% net impact score from Upright. Avantor seems to create the most significant positive value in categories "Taxes", "Physical diseases", and "Jobs". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Biochemical assay kits", "Chromatography columns", and "Single-use medical supplies" products. See details.
Environmental Sustainability
The Environmental Impact score for Avantor is -2.12.

1.9

News and Social Media Coverage

News Sentiment
Avantor has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.76 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 15 news articles for Avantor this week, compared to 4 articles on an average week.
MarketBeat Follows
Only 2 people have added Avantor to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Avantor insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $156,389.00 in company stock.
Percentage Held by Insiders
Only 1.50% of the stock of Avantor is held by insiders.
Percentage Held by Institutions
89.04% of the stock of Avantor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Avantor are expected to grow by 6.73% in the coming year, from $1.04 to $1.11 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Avantor is 39.59, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 109.88.
Price to Earnings Ratio vs. Sector
The P/E ratio of Avantor is 39.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.39.
Price to Earnings Growth Ratio
Avantor has a PEG Ratio of 1.31. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Avantor has a P/B Ratio of 2.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Avantor Stock (NYSE:AVTR)

Avantor, Inc. engages in the provision of mission-critical products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides logistics, chemical and equipment tracking, and glassware autoclaving, as well as scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.

AVTR Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AVTR Stock News Headlines

December 3, 2023 | americanbankingnews.com

Avantor, Inc. (NYSE:AVTR) Sees Large Increase in Short Interest

December 2, 2023 | americanbankingnews.com

Zacks Research Equities Analysts Boost Earnings Estimates for Avantor, Inc. (NYSE:AVTR)

December 3, 2023 | Wealthpress (Ad)

Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

December 1, 2023 | barrons.com

Avantor(R) Receives Top Score on Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index

December 1, 2023 | finance.yahoo.com

Avantor(R) Receives Top Score on Human Rights Campaign Foundation's 2023–2024 Corporate Equality Index

December 1, 2023 | seekingalpha.com

Avantor: Contracting Growth And Returns On Equity At 37x Earnings - Enemies To The Value Investor

December 1, 2023 | americanbankingnews.com

Avantor, Inc. to Post FY2024 Earnings of $1.09 Per Share, Zacks Research Forecasts (NYSE:AVTR)

November 30, 2023 | finance.yahoo.com

Avantor® Receives Top Score on Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index

December 3, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 25, 2023 | americanbankingnews.com

Avantor, Inc. (NYSE:AVTR) Receives $24.05 Average Price Target from Analysts

November 22, 2023 | finance.yahoo.com

Avantor® to Host Investor Day on December 8, 2023

November 16, 2023 | finance.yahoo.com

Avantor® to Participate in the 6th Annual Evercore ISI HealthCONx Conference

November 15, 2023 | finance.yahoo.com

Avantor's (AVTR) New Offerings to Aid Cell and Gene Therapy Suite

November 8, 2023 | finanznachrichten.de

Avantor: The Pharmaceutical Supply Chain Addresses The Renewable Energy Transition | Part 2

October 30, 2023 | finance.yahoo.com

The Avantor Inc (AVTR) Company: A Short SWOT Analysis

October 30, 2023 | msn.com

Avantor (AVTR) Q3 Earnings In-Line With Estimates, Revenues Top

October 30, 2023 | finance.yahoo.com

An Intrinsic Calculation For Avantor, Inc. (NYSE:AVTR) Suggests It's 34% Undervalued

October 30, 2023 | markets.businessinsider.com

Avantor’s Stock: A Buy Rating Amidst Challenges and Potential for Significant Growth

October 28, 2023 | finance.yahoo.com

Avantor, Inc. (NYSE:AVTR) Q3 2023 Earnings Call Transcript

October 28, 2023 | markets.businessinsider.com

Hold Rating on Avantor Amid Q4 Disappointments and Sector Volatility: An Analysis by Daniel Brennan

October 27, 2023 | finance.yahoo.com

Compared to Estimates, Avantor, Inc. (AVTR) Q3 Earnings: A Look at Key Metrics

October 27, 2023 | seekingalpha.com

Avantor, Inc. 2023 Q3 - Results - Earnings Call Presentation

October 27, 2023 | markets.businessinsider.com

Avantor, Inc Q3 Profit Drops, Inline With Estimates

October 27, 2023 | finance.yahoo.com

Avantor, Inc. (AVTR) Q3 Earnings Meet Estimates

October 27, 2023 | finance.yahoo.com

Avantor Inc (AVTR) Reports Q3 2023 Earnings: Net Sales Down 7.3%, Net Income of $108.4 Million

October 26, 2023 | markets.businessinsider.com

Avantor earnings: here's what Wall Street expects

October 12, 2023 | bizjournals.com

Women of Influence 2023: Deborah Poenisch, Avantor

See More Headlines

Receive AVTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avantor and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/27/2023
Today: 12/03/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/02/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Analytical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:AVTR
CUSIP: N/A
CIK: 1722482
Web: www.avantorsciences.com
Phone: (610) 386-1700
Fax: N/A
Employees: 14,500
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $24.05
High Stock Price Target: $30.00
Low Stock Price Target: $21.00
Potential Upside/Downside: +12.5%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.73
Research Coverage: 11 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.54
Trailing P/E Ratio: 39.59
Forward P/E Ratio: 20.56
P/E Growth: 1.31
Net Income: $686.50 million
Net Margins: 5.18%
Pretax Margin: 6.62%
Return on Equity: 15.34%
Return on Assets: 5.81%

Debt

Debt-to-Equity Ratio: 1.04
Current Ratio: 1.60
Quick Ratio: 1.03

Sales & Book Value

Annual Sales: $7.04 billion
Price / Sales: 2.05
Cash Flow: $2.04 per share
Price / Cash Flow: 10.47
Book Value: $7.54 per share
Price / Book: 2.84

Miscellaneous

Outstanding Shares: 676,386,000
Free Float: 666,240,000
Market Cap: $14.46 billion
Optionable: Not Optionable
Beta: 1.36

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Michael Stubblefield (Age 50)
President, CEO & Director
Comp: $1.15M
Dr. Gerard Brophy Ph.D. (Age 57)
Executive VP of Biopharma Production, Executive Officer & Chair of Scientific Advisory Board
Comp: $579.47k
Mr. Frederic Vanderhaegen (Age 56)
Executive Vice President of Europe
Comp: $666.12k
Ms. Sheri Lewis (Age 57)
Executive Vice President of Global Supply Chain
Comp: $490.62k
Mr. R. Brent Jones (Age 53)
Executive VP & CFO
Mr. Steven W. Eck (Age 46)
Senior VP, Corporate Controller & Chief Accounting Officer
Mr. Michael Wondrasch (Age 54)
Executive VP & Chief Information Officer
Comp: $808.63k
Mr. Tommy J. Thomas CPA
Vice President of Investor Relations
Mr. Claudius O. Sokenu (Age 55)
Executive VP, Corporate Secretary and Chief Legal & Compliance Officer
Ms. Allison K. Hosak
Senior Vice President of Global Communications & Brand

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

AVTR Stock Analysis - Frequently Asked Questions

Should I buy or sell Avantor stock right now?: 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" AVTR shares.
View AVTR analyst ratings or view top-rated stocks.
What is Avantor's stock price target for 2024?: 11 analysts have issued 12 month target prices for Avantor's shares. Their AVTR share price targets range from $21.00 to $30.00. On average, they predict the company's stock price to reach $24.05 in the next year. This suggests a possible upside of 12.5% from the stock's current price.
View analysts price targets for AVTR or view top-rated stocks among Wall Street analysts.
How have AVTR shares performed in 2023?: Avantor's stock was trading at $21.09 at the start of the year. Since then, AVTR shares have increased by 1.4% and is now trading at $21.38.
View the best growth stocks for 2023 here.
Are investors shorting Avantor?: Avantor saw a increase in short interest in November. As of November 15th, there was short interest totaling 31,680,000 shares, an increase of 9.1% from the October 31st total of 29,040,000 shares. Based on an average daily volume of 7,580,000 shares, the short-interest ratio is presently 4.2 days.
View Avantor's Short Interest.
When is Avantor's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, February 2nd 2024.
View our AVTR earnings forecast.
How were Avantor's earnings last quarter?: Avantor, Inc. (NYSE:AVTR) released its earnings results on Friday, October, 27th. The company reported $0.25 EPS for the quarter, hitting the consensus estimate of $0.25. The business had revenue of $1.72 billion for the quarter, compared to the consensus estimate of $1.70 billion. Avantor had a trailing twelve-month return on equity of 15.34% and a net margin of 5.18%. The company's revenue for the quarter was down 7.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.34 EPS.

What ETFs hold Avantor's stock?: ETFs with the largest weight of Avantor (NYSE:AVTR) stock in their portfolio include Harbor Health Care ETF (MEDI), Putnam BioRevolution ETF (SYNB), Nuveen ESG Mid-Cap Value ETF (NUMV), First Trust Health Care AlphaDEX Fund (FXH), Invesco Zacks Mid-Cap ETF (CZA), First Trust Innovation Leaders ETF (ILDR) and Natixis Vaughan Nelson Mid Cap ETF (VNMC).Vanguard Extended Market ETF (VXF).
What guidance has Avantor issued on next quarter's earnings?: Avantor issued an update on its FY 2023 earnings guidance on Friday, October, 27th. The company provided EPS guidance of $1.02-$1.06 for the period, compared to the consensus EPS estimate of $1.07. The company issued revenue guidance of -.
What other stocks do shareholders of Avantor own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), RTX (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).
When did Avantor IPO?: (AVTR) raised $3 billion in an initial public offering (IPO) on Friday, May 17th 2019. The company issued 154,000,000 shares at $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.
Who are Avantor's major shareholders?: Avantor's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Boston Partners (4.15%), Canada Pension Plan Investment Board (3.30%), Wellington Management Group LLP (1.34%), Meritage Group LP (1.32%), Robeco Schweiz AG (1.21%) and American Century Companies Inc. (1.13%). Insiders that own company stock include Christi Shaw, Christophe Couturier, David D Petratis, Devashish Ohri, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Justin Miller, Michael Stubblefield, Michael Wondrasch, Rajiv Gupta, Steven W Eck and Thomas A Szlosek.
View institutional ownership trends.
How do I buy shares of Avantor?: Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:AVTR) was last updated on 12/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Avantor Stock Price, News & Analysis (NYSE:AVTR)

Avantor MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

Environmental Sustainability

News and Social Media Coverage

News Sentiment

News Coverage This Week

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Avantor Stock (NYSE:AVTR)

AVTR Stock Price History

AVTR Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

AVTR Stock Analysis - Frequently Asked Questions

Overall MarketRank^™